Andere talen BioCryst Pharmaceuticals, Inc.

Aandelen

BCRX

US09058V1035

Beurs gesloten - Nasdaq Andere beurzen 22:00:00 10-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
5,32 ^USD	-0,37%		+19,55%	-11,19%

09/05	BioCryst presenteert nieuw real-world bewijs waaruit blijkt dat het gebruik van zorgbronnen bij patiënten met HAE aanzienlijk afneemt na het starten met ORLADEYO	CI
07/05	BIOCRYST PHARMACEUTICALS, INC. : JMP Securities herhaalt koopadvies voor het aandeel	ZM

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

BioCryst Presents New Real-world Evidence Showing Significant Reductions in Healthcare Resource Utilization Among Patients with HAE Following Initiation of ORLADEYO® (berotralstat)	09/05
BioCryst Presents New Real-world Evidence Showing Significant Reductions in Healthcare Resource Utilization Among Patients with HAE Following Initiation of ORLADEYO	09/05
BioCryst to Present at Upcoming Investor Conferences	07/05
BioCryst Pharmaceuticals, Freshpet rise; Luminar, Integra fall, Monday, 5/6/2024	06/05
Sector Update: Health Care Stocks Higher in Late Afternoon Trading	06/05
BioCryst Pharmaceuticals Shares Jump After Q1 Beat	06/05
BioCryst: Q1 Earnings Snapshot	06/05
BioCryst Reports First Quarter 2024 Financial Results and Provides Business Update	06/05
Biocryst Pharmaceuticals, Inc. Revises Revenue Guidance for the Year 2024	06/05
BioCryst Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	06/05
North American Morning Briefing : Stock Futures Rise as Hopes of Rate Cut Return	06/05
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	03/05
BioCryst to Report First Quarter 2024 Financial Results on May 6	22/04
BioCryst Pharmaceuticals Secures Approval for Orladeyo in Brazil	17/04
BioCryst Announces Approval of ORLADEYO® (berotralstat) by the Brazilian Health Regulatory Agency	17/04
BioCryst Pharmaceuticals, Inc. Announces Approval of ORLADEYO (berotralstat) by the Brazilian Health Regulatory Agency	17/04
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	03/04
BioCryst to Present at Upcoming Investor Conferences	25/03
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	05/03
BioCryst Pharmaceuticals Q4 Adjusted Loss Narrows as Revenue Increases	26/02

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen BioCryst Pharmaceuticals, Inc.

Aandelen

BCRX

US09058V1035

Andere talen

Filters